Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.
Wallonia HealthSpaces
Facilities Designed to Make Healthcare More Accessible
Key Investment Information Sheet
Terms & Conditions
Wallonia HealthSpaces generates revenue by developing local healthcare infrastructure and making it available to legally independent healthcare operators under long-term occupancy agreements.
The first project, Pôle Santé Bonaparte, is intended to serve as a pilot before the model is gradually rolled out across other sites in Wallonia.
Pôle Santé Bonaparte projections
For the first two full financial years, the financial plan forecasts:
- €45,600 in annual occupancy income;
- €5,000 in annual operating expenses;
- €40,600 in annual EBITDA.
Operating expenses mainly comprise insurance, accounting fees, bank charges and building management costs.
The company is expected to record an annual net loss of approximately €16,000 during each of the first two financial years, mainly due to depreciation of the building, works and equipment.
As depreciation does not represent a cash outflow, cash flow from operating activities is expected to remain positive at approximately €18,000 per year.
Development from the third year onwards
The financial plan provides for an increase in occupancy income after the first two years of operations.
Annual income would need to increase from approximately €45,600 to €67,400 to accommodate the evolution of the financial costs and maintain Wallonia HealthSpaces’ cash-flow balance.
This increase is a material assumption in the financial plan. It will depend on its contractual implementation with the healthcare operator, the development of Pôle Santé Bonaparte’s activities and the occupant’s financial capacity.
Sensitivity of the projections
During the first two financial years, the base-case scenario results in an operating cash flow that is close to break-even.
A decrease in occupancy income would have the following annual impact:
- if income were 10% lower, the cash deficit would be approximately €5,400 per year;
- if income were 20% lower, the cash deficit would be approximately €10,000 per year;
- if income were 10% higher, the company would generate a surplus of approximately €3,700 per year.
The stability of occupancy income and the control of operating costs are therefore the project’s main financial assumptions.
Long-term development
The business plan provides for the gradual development of Wallonia HealthSpaces based on the Bonaparte project:
- 2027: first site becomes operational;
- 2030: three to five structured or operational sites;
- 2034 to 2035: eight to ten sites within a consolidated network.
Under this development scenario, annual occupancy income could evolve as follows:
- approximately €45,600 from the first site;
- between €150,000 and €200,000 from three to five sites;
- between €380,000 and €450,000 from eight to ten sites.
Growth will depend on Wallonia HealthSpaces’ ability to identify suitable buildings, secure the necessary financing, complete the required works and enter into agreements with healthcare operators.
These projections are indicative objectives and do not constitute performance commitments.
Scorecard
The Scorecard is a tool designed to help investors make more informed decisions when considering investments in start-up companies. It provides an overview of a company's current situation. Developed by Spreds, it offers an objective score based on a defined set of key factors, often identified by academic research as indicators of a start-up's potential for success. The documents provided by the project owner were received by Spreds and made available to (potential) investors. The content of these documents was not analyzed by Spreds nor Spreds Finance.
Raise summary
| Crowd investments | €0 |
| Committed by others | €0 |
| Amount raised | €0 |
| Minimum round | €25,000 |
| Maximum round | €600,000 |
| Shares in the company (total round) | 66.667% |
| Pre-money valuation | €300,000 |
| Post-money valuation min. | €325,000 |
| Post-money valuation max. | €900,000 |